AGC
JNJ icon

Aspen Grove Capital’s Johnson & Johnson JNJ Stock Holding History

Aspen Grove Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$823K Buy
3,238
+22
+0.7% +$5.13K 0.12% 80
2026
Q1 		$786K Buy
3,216
+136
+4% +$31.7K 0.15% 74
2025
Q4 		$637K Sell
3,080
-239
-7% -$47.3K 0.11% 85
2025
Q3 		$616K Sell
3,319
-842
-20% -$144K 0.1% 87
2025
Q2 		$636K Buy
4,161
+803
+24% +$123K 0.11% 91
2025
Q1 		$557K Buy
3,358
+286
+9% +$44.7K 0.11% 109
2024
Q4 		$444K Sell
3,072
-166
-5% -$25.7K 0.09% 110
2024
Q3 		$525K Sell
3,238
-400
-11% -$63.7K 0.12% 96
2024
Q2 		$532K Sell
3,638
-238
-6% -$35.4K 0.13% 93
2024
Q1 		$613K Buy
3,876
+325
+9% +$51.7K 0.17% 82
2023
Q4 		$527K Buy
3,551
+361
+11% +$55.4K 0.16% 86
2023
Q3 		$497K Sell
3,190
-5,378
-63% -$887K 0.18% 86
2023
Q2 		$1.42M Buy
8,568
+672
+9% +$108K 0.46% 48
2023
Q1 		$1.22M Sell
7,896
-856
-10% -$138K 0.54% 43
2022
Q4 		$1.55M Buy
+8,752
New +$1.51M 0.72% 33

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Aspen Grove Capital's JNJ Position: Q2 2026 in Review

Aspen Grove Capital increased its Johnson & Johnson (JNJ) stake by 0.68% in Q2 2026, buying an estimated $5.13K and bringing the position to 3,238 shares worth $823K. The position accounts for 0.12% of the portfolio, ranked #80.

Aspen Grove Capital first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.55M in Q4 2022. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Aspen Grove Capital held 3,238 shares of Johnson & Johnson worth $823K as of Q2 2026.
  • Aspen Grove Capital bought 22 Johnson & Johnson shares in Q2 2026, an estimated $5.13K.
  • Johnson & Johnson made up 0.12% of Aspen Grove Capital's portfolio in Q2 2026, its #80 holding.
  • Aspen Grove Capital first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Aspen Grove Capital's Johnson & Johnson position peaked at $1.55M in Q4 2022.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Aspen Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.